Alliance Pharma Plc Stock Rating Reaffirmed by FinnCap (APH)
Alliance Pharma Plc (LON:APH)‘s stock had its “hold” rating reiterated by research analysts at FinnCap in a report released on Tuesday, American Banking & Market News reports. They currently have a GBX 38.50 ($0.63) target price on the stock. FinnCap’s target price suggests a potential upside of 14.31% from the stock’s previous close.
Alliance Pharma Plc (LON:APH) traded down 1.66% during mid-day trading on Tuesday, hitting GBX 33.68. The stock had a trading volume of 936,047 shares. Alliance Pharma Plc has a one year low of GBX 31.45 and a one year high of GBX 40.50. The stock has a 50-day moving average of GBX 37.57 and a 200-day moving average of GBX 35.51.
Separately, analysts at Numis Securities Ltd reiterated an “add” rating on shares of Alliance Pharma Plc in a research note to investors on Wednesday, December 18th. They now have a GBX 41 ($0.68) price target on the stock. One analyst has rated the stock with a sell rating and six have given a hold rating to the company’s stock. Alliance Pharma Plc has a consensus rating of “Hold” and a consensus target price of GBX 36.14 ($0.60).
Alliance Pharma plc is engaged in the acquisition, marketing and distribution of pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.